Mr. Visser reappointed as member of Supervisory Board
The Annual General Meeting of Shareholders of Mediq, international provider of pharmaceuticals and medical devices, has today approved the reappointment of Mr Visser, for a subsequent term of four years. Biense Visser has been a member of the Supervisory Board since 2003. He is the chairman of the Remuneration Committee.
The Meeting also adopted the proposal to distribute a dividend of € 0.46 per share in cash or shares. This represents an increase with 5%, and results in a pay-out of 35% of the net result, which is equal to our target ratio. The dividend will be made payable on 9 May, after the end of the cash or stock option dividend period.
In addition, the Meeting adopted the proposal to change to the English language as the language for the financial statements and the annual report.